| Study | Reason for exclusion |
|---|---|
| Baumhackl 2003 | Small cohort study carried out on 30 participants with confirmed diagnosis of multiple sclerosis |
| Craig 1999 | Cohort study to state an accelerated immunization schedule for military personnel or travellers |
| Dengler 1999 | Study carried out in heart transplanted recipients with the aim to evaluate vaccine efficacy in a risk population |
| Hedenstrom 1995 | Randomized study comparing the effect on immunogenicity and adverse events of TBE vaccine alone or TBE vaccine plus immunoglobulin in 128 adults; no unvaccinated or placebo groups |
| Leonova 2007 | Study in which antibody response to Encepur vaccine was determined; no control group |
| Mamoli 1981 | Randomized study comparing the effect of TBE vaccine and placebo on electroencephalogram (EEG) as a marker of a post‐vaccine reaction |
| Panasiuk 2003 | Small non‐randomized study (8 women, 21 men) carried out in HIV‐infected people to investigate immunogenicity and safety of the vaccine against TBE |
| Rosenkranz 1997 | Not original data; definition of equivalence criterion on data from Girgsdies 1996 |
| Schöndorf 2006 | No control group; effect of booster dose administration in participants who were already immunized with rapid schedule at least 2 years before |
| Vene 2007 | Not comparative design; serological comparison of 3 groups of participants with different immunization history |
| Zent 2003 | Multicentre study with no control group to investigate immune response after booster immunization with new TBE vaccine for adults (Encepur) |
| Zoulek 1986 | Small study (20 participants) comparing immune response following intradermal or intramuscular administration of FSME‐IMMUN to young adults in Germany; no randomization mentioned |
HIV: human immunodeficiency virus; TBE: tick‐borne encephalitis.